YE X, ABOU-RAYYAH Y, BISCHOFF J, RITCHIE A, SEBIRE NJ, WATTS P, CHURCHILL AJ and BATES DO, 2016. The Journal of pathology. 239(2), 139-51
JACKSON SJ, ANDREWS N, BALL D, BELLANTUONO I, GRAY J, HACHOUMI L, HOLMES A, LATCHAM J, PETRIE A, POTTER P, RICE A, RITCHIE A, STEWART M, STREPKA C, YEOMAN M and CHAPMAN K, 2016. Laboratory animals. 51(2), 160-169
SMITH SJ, RAHMAN CV, CLARKE PA, RITCHIE AA, GOULD TW, WARD JH, SHAKESHEFF KM, GRUNDY RG and RAHMAN R, 2014. Annals of the Royal College of Surgeons of England. 96(7), 495-501
RAHMAN CV, SMITH SJ, MORGAN PS, LANGMACK KA, CLARKE PA, RITCHIE AA, MACARTHUR DC, ROSE FR, SHAKESHEFF KM, GRUNDY RG and RUMAN RAHMAN, 2013. PloS one. 8(10), e77435
AIRD, RE, CUMMINGS, J, RITCHIE, AA, MUIR, M, MORRIS, RE, CHEN, H, SADLER, PJ and JODRELL, DI, 2002. In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer BRITISH JOURNAL OF CANCER. 86(10), 1652-1657
HAWKINS, RA, ARENDS, MJ, RITCHIE, AA, LANGDON, S and MILLER, WR, 2000. Tamoxifen increases apoptosis but does not influence markers of proliferation in an MCF-7 xenograft model of breast cancer BREAST. 9(2), 96-106
LANGDON, SP, GABRA, H, BARTLETT, JMS, RABIAZ, GJ, HAWKINS, RA, TESDALE, AL, RITCHIE, AA, MILLER, WR and SMYTH, JF, 1998. Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen CLINICAL CANCER RESEARCH. 4(9), 2245-2251
LANGDON, S, SETHI, T, RITCHIE, A, MUIR, M, SMYTH, J and ROZENGURT, E, 1992. BROAD-SPECTRUM NEUROPEPTIDE ANTAGONISTS INHIBIT THE GROWTH OF SMALL-CELL LUNG-CANCER INVIVO CANCER RESEARCH. 52(16), 4554-4557